The best tools for capturing patient-reported outcomes (PRO) are ones patients helped develop, according to recently published guidelines on PRO best practices that point to increased accessibility, decreased patient burden and improved data consistency as major benefits. Read More
The increasing adoption of decentralized trial methods has brought with it a number of benefits, most of which outweigh the challenges remote operations present. But data management hurdles, technology limitations and the possibility of over-burdening study participants with self-managed tasks all need to be overcome to make decentralization successful. Read More
When negotiating a clinical trial agreement (CTA), some of the most important provisions — and the most contentious — are those dealing with study data and intellectual property. Sponsors will want to own all the data, as well as any future inventions derived from it, but there are good reasons for sites to push back and insist on some exceptions. Read More
This is the last installment of a four-part CenterWatch Weekly series on the principles and best practices of setting investigator compensation levels that are both fair and compliant with federal laws. In this article, we look at how a large healthcare network built a hybrid compensation model using various methodologies.Read More
This is the third installment in a four-part CenterWatch Weekly series on the principles and best practices of setting investigator compensation levels that are both fair and compliant with federal laws. This week, we look at how methodologies for determining compensation can be combined and customized. Links to previous installments of the series are at the end of the article.Read More
This is the second in a four-part CenterWatch Weekly series on the principles and best practices of setting investigator compensation levels that are both fair and compliant with federal laws. This week, we look at various methodologies for determining compensation. Read More
This is the first in a four-part CenterWatch Weekly series on the principles and best practices of setting investigator compensation levels that are both fair and compliant with federal laws.Read More
Much of the conversation about research data these days centers on how important it is to protect sensitive patient information, particularly as technology makes data-sharing easier at the same time regulatory agencies are requiring sponsors and researchers to share the results of their trials. Read More
Quality metrics and their role as part of an overall quality management system (QMS) are an important component of clinical research, but not all sites use quality performance tracking tools to their maximum advantage: tracking quality performance and identifying areas for improvement. Academic and institutional researchers haven’t fully embraced the concept of taking methodical steps to examine operations across individual studies. Read More
The coronavirus pandemic has highlighted the effectiveness of large, multisite clinical trials run under master protocols, especially when it comes to evaluating multiple experimental treatment options simultaneously. Despite their advantages, there are some challenges and costs associated with running master protocol trials that the industry is still grappling with. Read More
